Home >
NEWS
The European Commission has approved Pfizer’s Xeljanz as a treatment for psoriatic arthritis (PsA), significantly expanding the drug’s scope.
European regulators are allowing use of Xeljanz (tofacitinib citrate) 5mg twice daily in combination with methotrexate for to treat active PsA in adults who have had an inadequate response or who have been intolerant to a prior disease-modifying anti-rheumatic..
2018-08-06
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection~The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients..
2017-03-11
New US nod for Merck's nausea and vomiting drug
US regulators have approved a single-dose version of Merck & Co's chemotherapy-associated nausea and vomiting drug Emend.The jab's use has been cleared, in combination with other anti-emetics, for the prevention of delayed nausea and vomiting in ad..
2016-08-24
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com
Address: 510# in Building 8 of North Area, Dayuan Industry Park, Xili, Nanshan District of Shenzhen,China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com